5Y Capital

5Y Capital is a private equity and venture capital firm based in Xuhui, Shanghai, China, founded in 2008 by Ken Shi and Richard Liu. The firm specializes in early-stage venture investments and is dedicated to supporting entrepreneurs in building their companies. With over USD 5 billion in capital under management, 5Y Capital attracts global investors, including sovereign wealth funds, endowments, foundations, family offices, and funds of funds. Formerly known as Morningside Venture Capital, 5Y Capital aims to foster innovation and growth in the entrepreneurial ecosystem.

Zhe Chen

Managing Director

Yu Cheng

Partner

Victor Jin

Managing Director

Xutian Jing

Managing Director

Levi Liu

Partner

Qin Liu

Founding Partner

Jerry Tong

Senior Investment Associate

Tony Yeung

Managing Director

Zeng Ying

Partner

Cloris You

Managing Director

Elwin Yuan

Partner

Yuan Ye

Partner

Bo Zhang

Managing Director

Fei Zhang

Partner

Fisher Zhang

Partner

He Kaiyan

investor

Past deals in New England

Hopewell Therapeutics

Seed Round in 2023
Hopewell Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing synthetic lipid-based drug delivery systems for gene therapy and gene editing. Founded in 2018, the company specializes in creating biodegradable lipid nanoparticles designed to enhance the delivery of nucleic acids. This innovative technology aims to improve the administration of genomic medicines, thereby supporting advancements in immunotherapy, gene therapy, and gene editing. Hopewell Therapeutics is dedicated to providing effective solutions for the challenges faced in the field of novel drug delivery systems, ultimately striving to facilitate better patient outcomes in the realm of genomic healthcare.

XYZ Robotics

Series B in 2022
XYZ Robotics Inc. specializes in automating picking, sorting, and packing operations using advanced 3D AI and robotic manipulation algorithms. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, the company aims to enhance logistics and manufacturing productivity. XYZ Robotics creates a versatile range of AI-powered robotic systems designed for applications such as robotic depalletizing, mixed case palletizing, piece picking, bin picking, and vision-guided assembly. Its innovative machine vision and intelligence software platform promotes efficiency across various industries, including automotive, pharmaceuticals, electronics, e-commerce, retail, and third-party logistics. By implementing AI technology and deep learning, XYZ Robotics facilitates efficient supply chain management, streamlining processes from batch picking to final packaging.

XtalPi Technology

Series D in 2021
XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

XYZ Robotics

Series B in 2021
XYZ Robotics Inc. specializes in automating picking, sorting, and packing operations using advanced 3D AI and robotic manipulation algorithms. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, the company aims to enhance logistics and manufacturing productivity. XYZ Robotics creates a versatile range of AI-powered robotic systems designed for applications such as robotic depalletizing, mixed case palletizing, piece picking, bin picking, and vision-guided assembly. Its innovative machine vision and intelligence software platform promotes efficiency across various industries, including automotive, pharmaceuticals, electronics, e-commerce, retail, and third-party logistics. By implementing AI technology and deep learning, XYZ Robotics facilitates efficient supply chain management, streamlining processes from batch picking to final packaging.

Coin Metrics

Series B in 2021
Coin Metrics Inc. is a provider of blockchain and cryptocurrency data analytics, based in Cambridge, Massachusetts. Founded in 2017, the company specializes in delivering market and network data, analytics, and research to various industries and institutions involved in crypto-assets. Its offerings include the CM Network Data Pro, which provides comprehensive historical data on top cryptocurrency assets, and the CM Market Data Feed, which standardizes trade, candle, and order book data from multiple exchanges. Additionally, Coin Metrics offers CM Reference Rates, which present fixed asset pricing in U.S. dollars. By focusing on transparency and actionable data, Coin Metrics aims to empower individuals and organizations to make informed financial decisions related to cryptocurrencies.

Stavvy

Series A in 2021
Stavvy, Inc. is a financial technology company based in Boston, Massachusetts, that specializes in a digital mortgage vendor platform aimed at transforming the lending experience. Founded in 2018 and originally named Stavros Technologies, the company provides tools such as Stavvy Connect, which facilitates secure communication and access to vendor data for mortgage banking professionals during the underwriting and settlement processes. Additionally, Stavvy Notarize enables title agents, lawyers, and notaries to conduct virtual closings and meetings in real-time using web conference technology. By eliminating paper-based processes and enhancing communication, Stavvy aims to improve operational efficiency while minimizing risk for its users in the mortgage industry.

XtalPi Technology

Series C in 2020
XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

XYZ Robotics

Series A in 2020
XYZ Robotics Inc. specializes in automating picking, sorting, and packing operations using advanced 3D AI and robotic manipulation algorithms. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, the company aims to enhance logistics and manufacturing productivity. XYZ Robotics creates a versatile range of AI-powered robotic systems designed for applications such as robotic depalletizing, mixed case palletizing, piece picking, bin picking, and vision-guided assembly. Its innovative machine vision and intelligence software platform promotes efficiency across various industries, including automotive, pharmaceuticals, electronics, e-commerce, retail, and third-party logistics. By implementing AI technology and deep learning, XYZ Robotics facilitates efficient supply chain management, streamlining processes from batch picking to final packaging.

XYZ Robotics

Series A in 2019
XYZ Robotics Inc. specializes in automating picking, sorting, and packing operations using advanced 3D AI and robotic manipulation algorithms. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, the company aims to enhance logistics and manufacturing productivity. XYZ Robotics creates a versatile range of AI-powered robotic systems designed for applications such as robotic depalletizing, mixed case palletizing, piece picking, bin picking, and vision-guided assembly. Its innovative machine vision and intelligence software platform promotes efficiency across various industries, including automotive, pharmaceuticals, electronics, e-commerce, retail, and third-party logistics. By implementing AI technology and deep learning, XYZ Robotics facilitates efficient supply chain management, streamlining processes from batch picking to final packaging.

XtalPi Technology

Series B in 2019
XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

Freight Farms

Venture Round in 2017
Freight Farms, Inc. specializes in manufacturing innovative crop production units constructed from up-cycled shipping containers. Its flagship product, the Leafy Green Machine, is a pre-assembled hydroponic farm capable of producing commercial-scale yields of various crops, including herbs like mint and basil, as well as different types of lettuce and hearty greens such as kale and cabbage. Founded in 2010 and based in Boston, Massachusetts, Freight Farms aims to provide access to fresh and affordable food in regions where traditional farming is not feasible due to climate constraints. The company's technology promotes local food economies and sustainable food systems by enabling high-yield crop production regardless of environmental conditions. It serves a diverse clientele, including business owners, soil farmers, schools, municipalities, and non-profits across the United States, Canada, and Europe.

Clean Membranes

Series A in 2011
Clean Membranes, Inc. is a technology company based in Lexington, Massachusetts, specializing in the production of advanced anti-fouling membranes for various water treatment applications. Established in 2008, the company develops proprietary membranes that utilize a smart copolymer technology to create hydrophilic surfaces. These membranes are designed to enhance water flow and improve filter performance while maintaining long operational lifetimes. Clean Membranes caters to a wide range of sectors, including municipal and industrial wastewater treatment, seawater desalination, and the food and pharmaceutical industries. The innovative design of their membranes offers superior fouling resistance and higher permeability, resulting in reduced manufacturing and operational costs compared to traditional membrane technologies. The company’s focus on water conservation and reuse positions it as a key player in addressing global water challenges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.